The marketing name is "smartwatch"; the filing name is a sensor stack. Granted patent US10729336B1, issued August 4, 2020, claims a wrist device whose CPC classifications run for dozens of entries — A61B 5/0404 (electrocardiography), A61B 5/02055 (blood-pressure-related measurement), A61B 5/0492 and 5/0496 (bioelectric sensing), motion classes, and health-informatics class G16H 40/20. Read together, that list is the ambition: a continuously-worn diagnostic instrument disguised as a watch.

On the record, the wearable-health bet is not about any single sensor. It is about co-location. The value proposition is that a device on your wrist all day can correlate heart rhythm, perfusion, and movement in ways a periodic clinic visit cannot. This patent's sprawling classification list is the engineering expression of that thesis — it claims the integration, not just one measurement.

Novel, or just renamed? Each individual sensing modality in the list is well-established medical art. The claim's interest is in the combination on a wrist-worn form factor and in the data pipeline that turns raw signals into health outputs. As always, the principle is old; the integration and the constraints of the form factor are where the defensible work sits.

The strategic frame is that 2020 is the year the wearable category committed to health as the durable differentiator. Step counts and notifications were commodities; FDA-adjacent sensing was not. A patent that stacks cardiac and vascular sensing on one wrist is a claim staked in the part of the market that carries regulatory moats and services revenue.

Scope, stated carefully: this is a granted patent with a broad title, but breadth of title is not breadth of claim. The enforceable scope is whatever the independent claim's limitations define, and a crowded field of wearable-sensing patents from Apple, Fitbit, Masimo, and others bounds any one grant's reach.

Follow the filing. The watch on every wrist today is the product; the 2020 multi-sensor docket is the plan it executed. The health platform was specified in the classification list before it was marketed in the keynote.